US Pharma MarketingA couple months in, impacts of US government
The latest findings are the first signals that show how many more older adults are on weight loss drugs — and the potential impact on healthcare spending. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR…
Nearly two months into a federal pilot program aimed at expanding access to weight loss drugs for seniors, uptake data and reported benefits are beginning to materialize.
The latest findings,
Source: Endpoints News